Logo image of Z

ZILLOW GROUP INC - C (Z) Stock Fundamental Analysis

NASDAQ:Z - Nasdaq - US98954M2008 - Common Stock - Currency: USD

74.91  -3.43 (-4.38%)

After market: 75.25 +0.34 (+0.45%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to Z. Z was compared to 64 industry peers in the Real Estate Management & Development industry. Z has a great financial health rating, but its profitability evaluates not so good. Z has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

Z had positive earnings in the past year.
In the past year Z had a positive cash flow from operations.
In the past 5 years Z always reported negative net income.
Z had a positive operating cash flow in 4 of the past 5 years.
Z Yearly Net Income VS EBIT VS OCF VS FCFZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

1.2 Ratios

Z has a Return On Assets (-1.92%) which is comparable to the rest of the industry.
Z has a Return On Equity (-2.31%) which is in line with its industry peers.
Industry RankSector Rank
ROA -1.92%
ROE -2.31%
ROIC N/A
ROA(3y)-1.95%
ROA(5y)-2.59%
ROE(3y)-2.68%
ROE(5y)-4.27%
ROIC(3y)N/A
ROIC(5y)N/A
Z Yearly ROA, ROE, ROICZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2 -4 -6 -8

1.3 Margins

Looking at the Gross Margin, with a value of 76.43%, Z belongs to the top of the industry, outperforming 88.33% of the companies in the same industry.
Z's Gross Margin has improved in the last couple of years.
Z does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y42.3%
GM growth 5Y9.85%
Z Yearly Profit, Operating, Gross MarginsZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

7

2. Health

2.1 Basic Checks

Z does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for Z has been increased compared to 1 year ago.
Z has more shares outstanding than it did 5 years ago.
The debt/assets ratio for Z has been reduced compared to a year ago.
Z Yearly Shares OutstandingZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
Z Yearly Total Debt VS Total AssetsZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Z has an Altman-Z score of 11.76. This indicates that Z is financially healthy and has little risk of bankruptcy at the moment.
Z has a better Altman-Z score (11.76) than 88.33% of its industry peers.
The Debt to FCF ratio of Z is 2.19, which is a good value as it means it would take Z, 2.19 years of fcf income to pay off all of its debts.
Z has a Debt to FCF ratio of 2.19. This is amongst the best in the industry. Z outperforms 85.00% of its industry peers.
Z has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.03, Z is in the better half of the industry, outperforming 78.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 2.19
Altman-Z 11.76
ROIC/WACCN/A
WACC8.67%
Z Yearly LT Debt VS Equity VS FCFZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

2.3 Liquidity

A Current Ratio of 2.81 indicates that Z has no problem at all paying its short term obligations.
Z's Current ratio of 2.81 is fine compared to the rest of the industry. Z outperforms 66.67% of its industry peers.
Z has a Quick Ratio of 2.81. This indicates that Z is financially healthy and has no problem in meeting its short term obligations.
Z has a better Quick ratio (2.81) than 73.33% of its industry peers.
Industry RankSector Rank
Current Ratio 2.81
Quick Ratio 2.81
Z Yearly Current Assets VS Current LiabilitesZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.87% over the past year.
The Revenue has grown by 14.96% in the past year. This is quite good.
Z shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.00% yearly.
EPS 1Y (TTM)7.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35%
Revenue 1Y (TTM)14.96%
Revenue growth 3Y-35.01%
Revenue growth 5Y-4%
Sales Q2Q%16.88%

3.2 Future

Z is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.37% yearly.
The Revenue is expected to grow by 16.40% on average over the next years. This is quite good.
EPS Next Y33.5%
EPS Next 2Y33.85%
EPS Next 3Y34.87%
EPS Next 5Y33.37%
Revenue Next Year14.62%
Revenue Next 2Y14.7%
Revenue Next 3Y14.69%
Revenue Next 5Y16.4%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Z Yearly Revenue VS EstimatesZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
Z Yearly EPS VS EstimatesZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

Z is valuated quite expensively with a Price/Earnings ratio of 54.68.
65.00% of the companies in the same industry are more expensive than Z, based on the Price/Earnings ratio.
Z's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 29.63.
Z is valuated quite expensively with a Price/Forward Earnings ratio of 40.96.
Z's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. Z is cheaper than 71.67% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of Z to the average of the S&P500 Index (22.68), we can say Z is valued expensively.
Industry RankSector Rank
PE 54.68
Fwd PE 40.96
Z Price Earnings VS Forward Price EarningsZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Z's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, Z is valued a bit cheaper than 68.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 70.7
EV/EBITDA 279.76
Z Per share dataZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

Z's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as Z's earnings are expected to grow with 34.87% in the coming years.
PEG (NY)1.63
PEG (5Y)N/A
EPS Next 2Y33.85%
EPS Next 3Y34.87%

0

5. Dividend

5.1 Amount

No dividends for Z!.
Industry RankSector Rank
Dividend Yield N/A

ZILLOW GROUP INC - C

NASDAQ:Z (2/21/2025, 8:00:02 PM)

After market: 75.25 +0.34 (+0.45%)

74.91

-3.43 (-4.38%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)02-11 2025-02-11/amc
Earnings (Next)04-29 2025-04-29/amc
Inst Owners86.43%
Inst Owner Change2.05%
Ins Owners2.17%
Ins Owner Change8.17%
Market Cap18.17B
Analysts75.86
Price Target91.85 (22.61%)
Short Float %6.59%
Short Ratio4.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.54%
Min EPS beat(2)-7.25%
Max EPS beat(2)18.32%
EPS beat(4)3
Avg EPS beat(4)14.23%
Min EPS beat(4)-7.25%
Max EPS beat(4)42.57%
EPS beat(8)7
Avg EPS beat(8)60.76%
EPS beat(12)11
Avg EPS beat(12)88.46%
EPS beat(16)14
Avg EPS beat(16)36.8%
Revenue beat(2)1
Avg Revenue beat(2)1.15%
Min Revenue beat(2)-0.4%
Max Revenue beat(2)2.69%
Revenue beat(4)3
Avg Revenue beat(4)2.15%
Min Revenue beat(4)-0.4%
Max Revenue beat(4)4.31%
Revenue beat(8)7
Avg Revenue beat(8)3.22%
Revenue beat(12)9
Avg Revenue beat(12)-8.49%
Revenue beat(16)11
Avg Revenue beat(16)-17.43%
PT rev (1m)3.33%
PT rev (3m)34.04%
EPS NQ rev (1m)9.77%
EPS NQ rev (3m)5.79%
EPS NY rev (1m)3.49%
EPS NY rev (3m)3.44%
Revenue NQ rev (1m)1.34%
Revenue NQ rev (3m)0.62%
Revenue NY rev (1m)0.26%
Revenue NY rev (3m)-0.44%
Valuation
Industry RankSector Rank
PE 54.68
Fwd PE 40.96
P/S 8.13
P/FCF 70.7
P/OCF 42.45
P/B 3.75
P/tB 9.99
EV/EBITDA 279.76
EPS(TTM)1.37
EY1.83%
EPS(NY)1.83
Fwd EY2.44%
FCF(TTM)1.06
FCFY1.41%
OCF(TTM)1.76
OCFY2.36%
SpS9.22
BVpS19.99
TBVpS7.5
PEG (NY)1.63
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.92%
ROE -2.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.43%
FCFM 11.49%
ROA(3y)-1.95%
ROA(5y)-2.59%
ROE(3y)-2.68%
ROE(5y)-4.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y42.3%
GM growth 5Y9.85%
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 2.19
Debt/EBITDA 2.42
Cap/Depr 68.4%
Cap/Sales 7.65%
Interest Coverage N/A
Cash Conversion 713.33%
Profit Quality N/A
Current Ratio 2.81
Quick Ratio 2.81
Altman-Z 11.76
F-Score6
WACC8.67%
ROIC/WACCN/A
Cap/Depr(3y)77.3%
Cap/Depr(5y)82.19%
Cap/Sales(3y)7.76%
Cap/Sales(5y)5.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35%
EPS Next Y33.5%
EPS Next 2Y33.85%
EPS Next 3Y34.87%
EPS Next 5Y33.37%
Revenue 1Y (TTM)14.96%
Revenue growth 3Y-35.01%
Revenue growth 5Y-4%
Sales Q2Q%16.88%
Revenue Next Year14.62%
Revenue Next 2Y14.7%
Revenue Next 3Y14.69%
Revenue Next 5Y16.4%
EBIT growth 1Y23.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year451.84%
EBIT Next 3Y101.35%
EBIT Next 5Y64.13%
FCF growth 1Y35.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y20.9%
OCF growth 3YN/A
OCF growth 5YN/A